ArticleCancers2022

Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland.

Agnieszka Irena Jagiełło-Gruszfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.